Member Info for Timster

why would you want to work for this shody outfit :)

absolutely.... the concerned holders don't concern me one bit

https://bit.ly/3qWHJE8

It's also safe to say that everyone actually invested here is aware, surescreen, mologic other companies are working on tests. Avacta isn't the only company in the world with an lft in development. Early indications are it's the best spike protein test in the world but not the only one.

8th Feb

Partnership to accelerate CE marking of Avacta's SARS-CoV-2 rapid antigen test and support COVID-19 testing in low and middle income countries

Avacta Group plc (AIM: AVCT), the developer of Affimer® biotherapeutics and reagents, announces that it has entered into a commercial partnership with Mologic Ltd ("Mologic") to accelerate to market Avacta's AffiDX™ SARS-CoV-2 lateral flow rapid antigen test. Avacta will also support antigen testing in low and middle income countries[1] by providing access to Avacta's spike antigen test through Mologic.

The partnership will provide a faster route to market for Avacta's rapid antigen test by CE marking it for professional use under Mologic's existing ISO13485 quality system. The CE mark will then be transferred to Avacta when it receives ISO13485 accreditation, which is expected by the end of March 2021.

https://www.lse.co.uk/rns/AVCT/commercial-partnership-with-mologic-g2zjd7jhz488cm0.html

8th Feb

Partnership to accelerate CE marking of Avacta's SARS-CoV-2 rapid antigen test and support COVID-19 testing in low and middle income countries



Avacta Group plc (AIM: AVCT), the developer of Affimer® biotherapeutics and reagents, announces that it has entered into a commercial partnership with Mologic Ltd ("Mologic") to accelerate to market Avacta's AffiDX™ SARS-CoV-2 lateral flow rapid antigen test. Avacta will also support antigen testing in low and middle income countries[1] by providing access to Avacta's spike antigen test through Mologic.



The partnership will provide a faster route to market for Avacta's rapid antigen test by CE marking it for professional use under Mologic's existing ISO13485 quality system. The CE mark will then be transferred to Avacta when it receives ISO13485 accreditation, which is expected by the end of March 2021.

https://www.lse.co.uk/rns/AVCT/commercial-partnership-with-mologic-g2zjd7jhz488cm0.html

and the beauts continue to arrive!

is it the clown tour bus today richob?

seems everyone wants to use Mologic's ISO system to CE mark.

Good job we got in first and are nearly there

after a 50% rise in a month I'd say 5.8% is a tiny pull back

SP drops slightly after rising nearly 50% in a month and all the beauts arrive......

100% a massive improvement on Giles

29 mins in Alistair states what I quoted "think about what we WILL deliver"

LFT is coming very very soon

"Affimer platform very well known globally, think about what we WILL deliver shortly in just over 12 months, is a hell of an achievement"

good effort wolves! I'm ****ting it after the interview....

Mind boggling! so many life changing value infection points....

I'd say your investment is in safe hands....

dreamy.... :)

Burgundy, mix it up a bit

@radia it's a big hint Paul has fallen in love with our shumper leader, and to be honest who can blame him :)

In an attempt to reach maximum sensitivity I guess.
Much like avacta will when they create the combined test with mologic' s reagents. Which will create the ultimate 3rd generation lateral flow test.

Sure we could brew up a new Affimer in a few weeks that binds. If it became necessary.